When you’re using Ozempic, Wegovy, Mounjaro, or Zepbound, your GLP‑1 treatment can stay clear and organized in one place.
With Dailivity, keep injections, side effects, and health metrics in one calm, easy-to-understand view.
We’re here for your GLP‑1 journey.
Inside the app
Each screen in Dailivity simplifies one task, so small daily check-ins gradually become a clearer picture.
Estimated drug level
Using the doses and timing you log, Dailivity visualises the likely course of medication in your body in one clear chart.
This is an informational estimate based on published pharmacokinetic averages and must not be used to make personal dosing decisions.
Keep your plan visible
Medication, amount, the next date, and your history move together. The detail you need is there when it matters.
Understand your progress
Weight, body measurements, and treatment history meet in one clear view you can revisit and understand.
Stay prepared
Bring the records you choose into a PDF for your clinician, while keeping your remaining doses and reminders in the same calm plan.
Connect with your daily rhythm
Water, protein, and nutrition goals stay in the real context of your day, not apart from your treatment data.
Keep injection sites visible
Choose the injection site from a map or list, then keep recent records visible so your own routine stays easy to follow.
Connected to Apple Health
Import the weight, height, and nutrition measurements you choose from Apple Health, so your everyday view stays current.
Guides
Evidence-based guides covering the questions people ask most when starting GLP-1 therapy.
Articles
Explore leading coverage and research roundups on GLP-1 therapies in one place.
New data connects GLP-1 treatment with lower mortality for hospitalized Covid patients.
A look at how brain-gut pathways reshaped the understanding of GLP-1 medications.
Clinical review of current and emerging receptor agonists across the GLP-1 class.
SELECT trial findings on semaglutide’s impact on cardiovascular risk in obesity.
Emerging research into GLP-1 therapies for conditions beyond weight management.
Editorial overview of benefits, risks, and access questions around GLP-1 drugs.
Frequently Asked Questions
The questions we get asked most about GLP-1 tracking, data privacy, subscriptions and app features.
Dailivity is an iOS medication tracking app built for people on GLP-1 therapy. It records your injection dates and doses, reminds you when the next dose is due, logs side effects day by day, and charts health metrics such as weight, BMI, water and protein in a single view.
You can track GLP-1 receptor agonists containing semaglutide, tirzepatide, liraglutide and dulaglutide — including Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Trulicity and Victoza. Dose amount and injection interval are fully configurable.
Yes. Dailivity is completely free to use. Medication tracking, advanced charts, PDF/CSV export and estimated drug levels are all available at no cost.
Your data is stored locally on your device. If you enable sync, it is backed up encrypted to your own personal iCloud account through Apple CloudKit. No health data is kept on Dailivity servers, nothing is shared with third parties, and no account is required to use the app.
You set your injection day and time once, and Dailivity sends an iOS notification for every dose cycle while showing a smart countdown to your next dose on the home screen. Reminder time and frequency can be changed at any point.
On the side effect screen you record symptoms such as nausea, constipation or fatigue along with severity and date. You can see how they change over time on a chart, compare them against dose escalations, and export the log as a PDF to bring to your next appointment.
Yes. With your permission Dailivity integrates with Apple Health so you can import and keep weight and other health measurements in sync. You can revoke the integration at any time from iOS settings.
Estimated drug level visualises the likely course of the active ingredient in your body based on the doses and injection times you logged. It is an informational estimate derived from general pharmacokinetic averages and must not be used to make dosing decisions.
Dailivity is currently available on the App Store for iPhone and iPad only. An Android version is in progress — email support@dailivity.com if you would like to be notified when it launches.
No. Dailivity is a tracking and organisation tool. It does not provide medical advice, diagnosis or treatment and is not a medical device. Always consult your clinician or pharmacist before changing a dose or your treatment plan.